10x Genomics, Inc. (TXG) has 12 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 10 sales totalling $10.8M. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 9, 2026 | Taich Adam Chief Financial Officer | −$2,995,470 | 46,388 | −13% | Yes | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | STUELPNAGEL JOHN R Director | −$1,235,072 | 20,000 | −6% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Saxonov Serge Chief Executive Officer | $0 | 100 | −0% | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 26, 2026 | Saxonov Serge Chief Executive Officer | −$667,901 | 10,486 | −1% | Yes | |
|
|
||||||
| Aug. 26, 2026 filed Aug. 24, 2026 | Saxonov Serge Chief Executive Officer | −$1,168,775 | 18,545 | −2% | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free